全文获取类型
收费全文 | 4308篇 |
免费 | 352篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 97篇 |
妇产科学 | 56篇 |
基础医学 | 742篇 |
口腔科学 | 80篇 |
临床医学 | 420篇 |
内科学 | 729篇 |
皮肤病学 | 85篇 |
神经病学 | 775篇 |
特种医学 | 224篇 |
外科学 | 385篇 |
综合类 | 61篇 |
一般理论 | 3篇 |
预防医学 | 285篇 |
眼科学 | 52篇 |
药学 | 290篇 |
中国医学 | 5篇 |
肿瘤学 | 363篇 |
出版年
2024年 | 1篇 |
2023年 | 49篇 |
2022年 | 38篇 |
2021年 | 136篇 |
2020年 | 111篇 |
2019年 | 155篇 |
2018年 | 150篇 |
2017年 | 126篇 |
2016年 | 152篇 |
2015年 | 176篇 |
2014年 | 225篇 |
2013年 | 234篇 |
2012年 | 415篇 |
2011年 | 405篇 |
2010年 | 239篇 |
2009年 | 218篇 |
2008年 | 326篇 |
2007年 | 313篇 |
2006年 | 283篇 |
2005年 | 227篇 |
2004年 | 202篇 |
2003年 | 186篇 |
2002年 | 148篇 |
2001年 | 31篇 |
2000年 | 34篇 |
1999年 | 29篇 |
1998年 | 17篇 |
1997年 | 7篇 |
1996年 | 10篇 |
1995年 | 9篇 |
1994年 | 4篇 |
1993年 | 4篇 |
1990年 | 3篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1981年 | 1篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1975年 | 1篇 |
1964年 | 1篇 |
1958年 | 1篇 |
排序方式: 共有4674条查询结果,搜索用时 15 毫秒
1.
Paul G. Richardson Fredrik Schjesvold Katja Weisel Philippe Moreau Larry D. Anderson Darrell White Paula Rodriguez-Otero Pieter Sonneveld Monika Engelhardt Matthew Jenner Alessandro Corso Jan Dürig Michel Pavic Morten Salomo Meral Beksac Albert Oriol Jindriska Lindsay Anna Marina Liberati Monica Galli Pawel Robak Alessandra Larocca Munci Yagci Filiz Vural Abraham S. Kanate Ruiyun Jiang Lara Grote Teresa Peluso Meletios Dimopoulos 《European journal of haematology》2022,108(1):73-83
2.
Sibylle M. Winter Katja Dittrich Peggy Dörr Judith Overfeld Imke Moebus Elena Murray Gergana Karaboycheva Christian Zimmermann Andrea Knop Manuel Voelkle Sonja Entringer Claudia Buss John-Dylan Haynes Elisabeth B. Binder Christine Heim 《Journal of child psychology and psychiatry, and allied disciplines》2022,63(9):1027-1045
3.
Florian Huemer Thomas Melchardt Bettina Jansko Adam Wahida Stefanie Jilg Philipp J. Jost Eckhard Klieser Katja Steiger Teresa Magnes Lisa Pleyer Sigrun Greil‐Ressler Christof Rass Richard Greil Alexander Egle 《European journal of haematology》2019,102(5):437-441
Acute myeloid leukemia (AML) is a disease of the elderly population and survival remains poor after failure of hypomethylating agents (HMA). The BCL‐2 inhibitor venetoclax demonstrated activity as monotherapy and in combination with chemotherapy or HMA in AML. In this case series, patients with secondary AML (sAML) not eligible for intensive chemotherapy and refractory to HMA were treated with venetoclax within a named patient program at our tertiary cancer center in Salzburg, Austria. Between April 2017 and September 2018, seven patients with sAML received venetoclax therapy. Two out of seven patients achieved a complete remission upon venetoclax initiation with a PFS of 505 days and 352 days and another patient achieved complete peripheral blood blast clearing within nine days after start of venetoclax. Among the venetoclax responders, primary refractory disease to prior HMA therapy was documented, 2 patients harbored IDH1/IDH2 mutations and one patient had an antecedent myeloproliferative neoplasm. High BCL‐2 and/or BIM expression in myeloblasts was found in venetoclax responders and response was significantly associated with overall survival (responders: 364 days versus non‐responders: 24 days, P = 0.018). Venetoclax monotherapy is safe and is able to induce durable responses in elderly patients with secondary AML after treatment failure with HMA. 相似文献
4.
5.
Raquel Blazquez Eva Rietkötter Britta Wenske Darius Wlochowitz Daniela Sparrer Elena Vollmer Gunnar Müller Julia Seegerer Xueni Sun Katja Dettmer Alonso Barrantes-Freer Lena Stange Kirsten Utpatel Annalen Bleckmann Hannes Treiber Hanibal Bohnenberger Christof Lenz Matthias Schulz Christian Reimelt Christina Hackl Marian Grade Deram Büyüktas Laila Siam Marko Balkenhol Christine Stadelmann Dieter Kube Michael P. Krahn Martin A. Proescholdt Markus J. Riemenschneider Matthias Evert Peter J. Oefner Chistoph A. Klein Uwe K. Hanisch Claudia Binder Tobias Pukrop 《International journal of cancer. Journal international du cancer》2020,146(11):3170-3183
6.
7.
Johanna RANTANEN Taru FELDT Jari J HAKANEN Katja KOKKO Mari HUHTALA Lea PULKKINEN Wilmar SCHAUFELI 《Industrial health》2015,53(2):113-123
Abstract: The present study investigated the factor structure of the 10-item version of
the Dutch Work Addiction Scale (DUWAS). The DUWAS-10 is intended to measure workaholism
with two correlated factors: working excessively (WE) and working compulsively (WC). The
factor structure of the DUWAS-10 was examined among multi-occupational samples from the
Netherlands (n=9,010) and Finland (n=4,567) using
confirmatory factor analysis (CFA). CFAs revealed that the expected correlated two-factor
solution showed satisfactory fit to the data. However, a second-order factor solution,
where WE comprised the first-order factors “working frantically” and “working long hours”,
and WC the first-order factors “obsessive work drive” and “unease if not working”, showed
significantly better fit to the data. The expectation of factorial group invariance of the
second-order factor structure between the Dutch and Finnish samples was also supported.
Moreover, factorial time invariance was observed across a two-year time lag in a
sub-sample of Finnish managers (n=459). In conclusion, the DUWAS-10 was
found to be a comprehensive measure of workaholism, meeting the criteria of factorial
validity in multiple settings, and can thus be recommended for use in both research and
practice. 相似文献
8.
Katja Kobow Christopher A. Reid Erwin A. van Vliet Albert J. Becker Gemma L. Carvill Alica M. Goldman Shinichi Hirose Iscia Lopes-Cendes Hela Mrabet Khiari Annapurna Poduri Michael R. Johnson David C. Henshall 《Epileptic Disord》2020,22(2):127-141
Epigenetics refers broadly to processes that influence medium to long‐term gene expression by changing the readability and accessibility of the genetic code. The Neurobiology Commission of the International League Against Epilepsy (ILAE) recently convened a Task Force to explore and disseminate advances in epigenetics to better understand their role and intersection with genetics and the neurobiology of epilepsies and their co‐morbidities, and to accelerate translation of these findings into the development of better therapies. Here, we provide a topic primer on epigenetics, explaining the key processes and findings to date in experimental and human epilepsy. We review the growing list of genes with epigenetic functions that have been linked with epilepsy in humans. We consider potential practical applications, including using epigenetic signals as biomarkers for tissue‐ and biofluid‐based diagnostics and the prospects for developing epigenetic‐based treatments for epilepsy. We include a glossary of terms, FAQs and other supports to facilitate a broad understanding of the topic for the non‐expert. Last, we review the limitations, research gaps and the next challenges. In summary, epigenetic processes represent important mechanisms controlling the activity of genes, providing opportunities for insight into disease mechanisms, biomarkers and novel therapies for epilepsy. 相似文献
9.
A prospective three‐step intervention study to prevent medication errors in drug handling in paediatric care 下载免费PDF全文
10.
Katja T. Turunen Vasiliki Pletsa Panagiotis Georgiadis John K. Triantafillidis Dimitrios Karamanolis 《Nutrition and cancer》2016,68(4):560-567
The aim of the study was to determine the effect of β-glucan on the cytotoxicity and genotoxicity of polypectomized patient's fecal water (FW). Polypectomized volunteers (n = 69) were randomly assigned to consume bread with or without β-glucan, for 3 months. FW was collected at the beginning (t = 0), the 30th and 90th day and 2 wk after the intervention. Cytotoxicity and genotoxicity were estimated on Caco-2 cells, using trypan blue exclusion test and comet assay, respectively. Gastrointestinal symptoms were recorded and subjects kept a 3-day food diary at baseline and after completion. Trypan blue exclusion test revealed cell survival of approximately 87% after incubation with FW. The FW samples showed 49% genotoxicity at the baseline. Genotoxicity in the intervention group decreased during the trial reaching statistical significance on the 90th day compared to control. An increase was noticed 2 wk after the trial, but it still remained significantly lower compared to control. Group-specific analysis for β-glucan also revealed significant decrease in the genotoxicity on the 90th day compared to baseline. β-glucan ingestion in polypectomized patients significantly decreased the genotoxicity of their FW. Our findings suggest that β-glucan consumption could possibly provide protection against colon cancer development. 相似文献